Skip to main content
. 2020 Jun 15;36(8):e3335. doi: 10.1002/dmrr.3335

FIGURE 4.

FIGURE 4

Effects of treatments on quality of life. Canagliflozin improved quality of life (QoL) as shown in the Minnesota Living with Heart Failure Questionnaire (MLHFQ) score, where a reduction in the score suggests improvements in QoL. Data are presented as mean ± SD. MD, mean difference between groups